Metabolic therapy in the comprehensive treatment of patients with comorbidity of chronic pancreatitis and stable coronary artery disease

Journal Title: Гастроентерологія - Year 2017, Vol 51, Issue 1

Abstract

Metabolic therapy is one of the few ways to restore normal functions of all the vital organs and systems. The goal of the research was to explore the effectiveness of a course of treatment using metabolic drug Vazonat (meldonium dihydrate) to correct prooxidant-antioxidant and trophological disorders in patients with comorbid course of chronic pancreatitis (CP) and stable coronary artery disease (SCAD). The study included 90 patients with CP in combination with SCAD, who were divided into two groups (depending on the treatment program): I group (45 patients) received conventional treatment (CT); group II (45 patients) in addition to CT received Vazonat as follows: 5 ml intravenous bolus injection 1 time a day for 10 days followed by administration of 1 capsule (250 mg), 2 times per day for one month. It has been shown that the addition of Vazonat to the treatment of patients with comorbidity of CP and SCAD is more conducive to improving the performance and trophological prooxidant-antioxidant status than the standard basic therapy.

Authors and Affiliations

L. S. Babinets, N. A. Melnyk

Keywords

Related Articles

The role of gender dimorphism in the development and outcome of chronic viral hepatitis

Chronic viral liver diseases still have a leading place in the structure of mortality from hepatobiliary diseases and causes of liver transplantation. Search for factors influencing the progression of fibrosis and the pr...

Possibilities and Problems of Hepatoprotectors Application in Patients with Chronic Hepatitic C and Concomitamt Autoimmune Syndrome

A study of clinical and biochemical parameters of hepatoprotectors efficiency in 32 patients with chronic hepatitis C without signs of cirrhosis and with concomitant autoimmune component has been carried out. A significa...

Raphacholin C Efficiency in Comprehensive Treatment of Patients with Sphincter of Oddi Dysfunction after Cholecystectomy

The results of a complete physical examination and treatment in 40 patients with sphincter of Oddi dysfunction after cholecystectomy are provided. The clinical effectiveness of Raphacholin C, a herbal preparation, in com...

Features of Treatment of Patients Infected with Hepatitis C Virus Genotypes 1 And 4 by Direct-Acting Antiviral Drugs

Hepatitis C is an urgent problem today because of the low efficiency and a significant number of side effects of conventional therapy. The problem of the treatment of hepatitis C virus (HCV) genotypes 1 and 4 is particul...

Evaluation of Selenium Deficiency and Its Treatment Using Сefasel in Patients with Gastroenterological Diseases

The article presents research data on selenium deficiency in patients with chronic gastritis, chronic pancreatitis, chronic hepatitis, nonspecific inflammatory bowel diseases. It was found that selenium deficiency in pat...

Download PDF file
  • EP ID EP212795
  • DOI 10.22141/2308-2097.51.1.2017.97867
  • Views 69
  • Downloads 0

How To Cite

L. S. Babinets, N. A. Melnyk (2017). Metabolic therapy in the comprehensive treatment of patients with comorbidity of chronic pancreatitis and stable coronary artery disease. Гастроентерологія, 51(1), 16-21. https://europub.co.uk/articles/-A-212795